Global Dental Anesthesia Market, By Product Type (Lidocaine, Mepivacaine, Prilocaine, Articaine, and Other Product Types), By Anesthesia Type (Local, General, Sedation), By Distribution Channel, By End-Use, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032
- Published date: Jan 2022
- Report ID: 103970
- Number of Pages: 326
- Report Overview
- Driving Factors
- Restraining Factors
- COVID-19 Impact Analysis
- By Product Type Analysis
- By Anesthesia Type Analysis
- By Distribution Channel Analysis
- By End-Use Analysis
- Dental Anesthesia Key Market Segments
- Growth Opportunity
- Latest Trends
- Regional Analysis
- Key Regions and Countries
- Market Share & Key Players Analysis:
- Recent Developments:
- Report Scope:
In 2022, the global dental anesthesia market was valued at USD 2.3 billion. It is expected to reach USD 3.8 billion in 2032 growing at a CAGR of 5.3% between 2023-2032. Dental anesthesia refers to the administration of medications or techniques used to numb or sedate a patient during dental procedures. It helps to alleviate pain and discomfort, allowing the dentist to perform necessary treatments while ensuring the patient’s comfort.
Dental anesthesia is commonly used during tooth extractions to numb the area around the tooth being removed. It helps to minimize pain and discomfort during the procedure. It is utilized during various gum treatments, such as scaling and root planing (deep cleaning) or gum surgery (gingivectomy or gum grafting). It helps to numb the gums, making the procedure more comfortable for the patient. It is also used during the placement of dental implants, which are artificial tooth roots.
It ensures that the patient does not feel any pain or discomfort during the surgical procedure. The rising incidences of various dental diseases, the increasing geriatric population, and new innovations in dental surgery are major factors that have propelled the demand for dental anesthesia. Additionally, growing awareness about oral health, the development of the dental tourism industry, along with key R&D investments by private as well as government organizations are expected to fuel the dental anesthesia market growth during the projection period.
Rising Prevalence of Different Dental Diseases
The 2022 WHO Oral Health Status Report estimates that dental diseases affect almost 75% of people living in developing countries. Dental disorders impact about 3.5 billion people around the globe. As per the same data, permanent teeth caries affects about 2 billion individuals over the world. Approximately 500,000 Americans acquire implants each year, and 3 million adults in the U.S. have dental implants, as per the American Academy of Implant Dentistry.
In 2020, approximately 40.99 million persons wore full or partial dentures due to many missing teeth. Thus, the rising prevalence of dental diseases is anticipated to drive the demand for dental anesthesia, and this is a key factor driving the dental anesthesia market growth during the projection period.
Growing Dental Tourism Industry
Dental tourists often seek out countries that offer advanced or specialized dental treatments at a lower cost than in their home countries. These treatments may involve complex procedures that require the use of dental anesthesia. Dental treatments, including anesthesia, can be more affordable in certain countries due to lower labor and operational costs. This cost advantage may attract dental tourists, leading to increased demand for dental anesthesia in those destinations.
Dental tourism hotspots often have a well-established infrastructure with experienced dental professionals who are trained in providing anesthesia during dental procedures. This availability of skilled practitioners can enhance the appeal of dental tourism, further driving the demand for dental anesthesia. Therefore, the growing dental tourism industry is expected to stimulate the growth of the dental anesthesia market during the estimated time period.
Advancements in Dental Techniques
Advancements in dental technology and techniques have expanded the range of treatments available to patients. More complex procedures, such as dental implants or advanced reconstructive surgeries, may require various levels of anesthesia to ensure patient comfort and successful outcomes. As dental practices continue to evolve, the demand for anesthesia in these procedures is likely to increase. Thus, advancements in dental techniques are expected to fuel the growth of the dental anesthesia market during the forecast period.
Complications and Risks Involved in Dental Anesthesia
Excessive doses or accidental intravascular injection of local anesthetics can lead to systemic toxicity. Symptoms may include dizziness, light-headedness, confusion, seizures, or cardiac arrhythmias. Proper administration techniques, aspiration to ensure correct needle placement, and adherence to recommended maximum doses help minimize the risk of local anesthetic toxicity. Dental anesthesia involves administering anesthetics near nerves to block pain signals.
However, in rare cases, nerve damage can occur, resulting in temporary or permanent numbness, tingling, or loss of sensation in the tongue, lips, or surrounding areas. Skilled administration techniques, proper knowledge of anatomy, and careful monitoring can help reduce the risk of nerve injury. Thus, complications and risks involved in dental anesthesia may limit the dental anesthesia market growth during the projected time period.
Dental anesthesia, particularly general anesthesia, can be costly due to the specialized training and equipment required. The cost of anesthesia may add to the overall expense of dental procedures, especially for patients without insurance coverage. Higher costs may discourage some individuals from opting for anesthesia, particularly if they perceive the procedure to be less invasive or if they have financial constraints. Thus, the high cost involved in dental anesthesia is expected to have a negative impact on the growth of the dental anesthesia market over the forecast period.
Availability of Alternative Options
Advances in dental technology and techniques have led to the development of minimally invasive procedures. These treatments aim to reduce discomfort and the need for extensive anesthesia. With the availability of less invasive options such as laser dentistry or air abrasion, patients may choose these procedures that require minimal or no anesthesia, depending on the case. Therefore, the presence of alternative options may restrain the dental anesthesia market growth during the estimated time period.
COVID-19 Impact Analysis
During the initial phases of the pandemic, many dental clinics and practices were temporarily closed or limited to providing emergency dental care only. Non-essential dental procedures, including those requiring anesthesia, were postponed or canceled. This resulted in a significant reduction in the demand for dental anesthesia. Dental practices had to prioritize infection control measures and patient safety during the pandemic.
This led to changes in treatment protocols and increased focus on implementing stringent hygiene practices and reducing the risk of viral transmission. While dental anesthesia remained important for certain procedures, the emphasis shifted to managing essential and emergency treatments rather than elective procedures that would require anesthesia. It also negatively impacted the growth of the dental anesthesia market. However, due to rising awareness regarding dental diseases, the market is likely to witness significant growth in the post-pandemic phase.
By Product Type Analysis
Lidocaine is Witnessing Highest Growth
The lidocaine segment leads the dental anesthesia market in 2022 with the largest revenue share of 31%. Lidocaine is highly effective in providing local anesthesia for dental procedures. It rapidly numbs the target area and provides a relatively long duration of pain relief. Lidocaine can be used for various dental procedures, ranging from simple restorative work to more complex oral surgeries. It can be administered through various techniques, such as infiltration, nerve block, or topical application. Therefore, the high effectiveness and patient comfort offered by lidocaine are key factors stimulating the segment growth during the projection period.
Also, mepivacaine is expected to witness significant growth during the forecast period. Mepivacaine is another local anesthetic that is commonly used in dental anesthesia. It is a member of the amide class of local anesthetics, similar to lidocaine. While lidocaine is more widely used, mepivacaine has its own advantages and may be preferred in certain situations, contributing to its demand in dental anesthesia.
By Anesthesia Type Analysis
Local Anesthesia Finds Highest Demand
The local anesthesia segment is likely to lead the dental anesthesia market with a revenue share of 47% in the account. Local anesthetics, such as lidocaine and mepivacaine, are widely available and have a long history of safe use in dental practice. Their effectiveness and relatively low risk of adverse effects make them the preferred choice for dental anesthesia. Therefore, high availability and safety offered by local anesthetics are key factors driving the segment growth during the projection period.
Also, the general anesthesia segment is expected to grow at a high rate during the estimated time period. General anesthesia is often utilized in pediatric dentistry for young children who may struggle to remain still or cooperate during complex or lengthy procedures. It allows for effective treatment while minimizing anxiety and discomfort. Thus, a key role played by general anesthetics in pediatric dentistry is a major factor stimulating segment growth during the forecast period.
By Distribution Channel Analysis
Pharmacies and Drug Stores Dominate The Dental Anesthesia Market
The pharmacies and drug stores segment dominates the distribution channel segment by accounting for a revenue share of 50% in 2022. Dental anesthetics, such as lidocaine and mepivacaine, are commonly available in pharmacies and drug stores. These establishments typically stock a range of over-the-counter medications, including various types of local anesthetics.
Dental procedures that require local anesthesia, such as fillings, extractions, and root canals, are performed frequently. As a result, there is a consistent demand for dental anesthetics, prompting pharmacies and drug stores to carry these products. Patients who experience dental pain or require minor oral procedures may seek temporary relief from over-the-counter dental anesthetics.
These products provide localized pain relief and are sought after by individuals looking for quick and convenient solutions. Therefore, large-scale demand for dental anesthetics in common dental procedures, and high consumer demand, are key factors driving the segment growth over the forecast period.
Also, e-commerce is anticipated to witness high growth over the projection period. The growth of online shopping has expanded the availability of various products, including dental supplies and medications. This is a major factor fuelling the segment growth during the estimated time period.
By End-Use Analysis
Dental Clinics is the Major Segment
The dental clinics segment is expected to dominate the dental anesthesia market with a revenue share of 57% throughout the forecast period. Dental clinics have expanded their services to include more specialized treatments, such as root canals, dental implants, and oral surgeries. These procedures often require advanced anesthesia techniques and adequate pain control.
The demand for dental anesthesia rises in response to the increasing array of services offered by dental clinics. Therefore, high demand for dental anesthetics in complex dental procedures is a key factor that is likely to boost segment growth during the projection period.
Also, hospitals are anticipated to witness high growth during the projection period. Hospitals often have oral and maxillofacial surgery departments that handle complex surgeries involving the mouth, jaws, and facial structures. These surgeries may require the administration of dental anesthesia to facilitate pain control and optimal surgical outcomes. Therefore, the high demand for dental anesthetics in oral and maxillofacial surgeries in hospitals is likely to contribute to the segment growth during the estimated time period.
Dental Anesthesia Key Market Segments
- Other Product Types
- Pharmacies and Drug Stores
- Other Distribution Channels
- Dental Clinics
- Other End-uses
Rising Awareness Regarding Dental Diseases
With greater awareness about dental diseases and their potential consequences, more individuals are seeking dental care. People are becoming proactive in addressing oral health issues at an earlier stage, which can lead to more extensive dental treatments. Dental anesthesia becomes necessary for managing pain and discomfort during these treatments, ensuring that patients can undergo the necessary procedures without undue distress.
Advanced dental procedures, such as dental implants, complex restorations, and oral surgeries, are becoming more common as people become aware of the available treatment options. These procedures often involve invasive techniques and require anesthesia to ensure patient comfort during the process. Rising awareness about the benefits and success rates of such procedures contributes to the demand for dental anesthesia. Thus, rising awareness regarding dental diseases would promote the demand for dental anesthesia and provide new growth opportunities for the dental anesthesia market in the upcoming time period.
Advancements in Technology
New technologies are being explored to increase the effectiveness of dental anesthesia, as well as provide comfort to the patient. Computer-assisted anesthesia delivery systems, such as The Wand or Single Tooth Anesthesia (STA) system, use advanced technology to precisely control the flow and pressure of local anesthesia. These systems offer a more comfortable and accurate delivery of anesthesia, reducing the sensation of pain and improving patient experience. Also, needle phobia is a common concern among dental patients.
Needleless anesthesia technologies, such as jet injectors or transdermal patches, offer alternatives to traditional injections. Jet injectors use high-pressure streams to deliver anesthesia without needles, while transdermal patches release local anesthetics through the skin. These methods can help alleviate anxiety and discomfort associated with needles. Thus, such key technological advancements can be considered a positive trend and are likely to boost the growth of the dental anesthesia market in the upcoming time period.
Asia-Pacific Leads the Market By Holding a Major Revenue Share in the Account
The Asia-Pacific region is expected to hold the largest share of 40% in the dental anesthesia market during the projected time period. Improved economic conditions and increased availability of dental clinics have made dental care more affordable and accessible to a larger population in Asia. As dental treatments become more accessible, the demand for dental anesthesia for pain management during more complex procedures, such as dental implants, root canals, or oral surgeries, is also increasing.
Dental tourism is gaining popularity in Asia, with countries such as Thailand, Vietnam, India, and Malaysia attracting international patients seeking quality dental treatments at lower costs. Dental tourists often undergo extensive procedures that may require dental anesthesia for pain relief and comfort.
The growth of dental tourism in Asia contributes to the overall demand for dental anesthesia in the region. Thus, rising affordability and accessibility of dental care and growing dental tourism are major factors that are anticipated to boost the dental anesthesia market growth in the region throughout the forecast period.
Moreover, the North American region is likely to witness high growth during the estimated time period. North America has a significant aging population, and older adults often require dental treatments that involve more complex procedures. These may include tooth extractions, root canals, or restorative treatments.
Dental anesthesia is essential in managing pain and ensuring patient comfort during these procedures, leading to increased demand as the population ages. Also, North America is at the forefront of dental technology advancements. New techniques, equipment, and materials have made dental procedures more efficient and less invasive. Some advanced technologies, such as cone beam computed tomography (CBCT) imaging and computer-assisted anesthesia delivery systems, enable precise planning and administration of anesthesia.
These technological advancements contribute to the demand for dental anesthesia as they enhance the accuracy and effectiveness of treatment. Therefore, the rising geriatric population and technological advancements are key factors that are expected to fuel the expansion of the dental anesthesia market throughout the region during the projection period.
Key Regions and Countries
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- South America
- Rest of South America
- South Africa
- Rest of MEA
The global Dental Anesthesia market is highly competitive and comprises several large and small market players. The market is expected to grow at a high rate during the projection period due to significant advancements in dentistry. Additionally, key partnerships and collaborations, investments in technology, and product innovations by key market players are likely to contribute to market growth in the upcoming years.
Top Key Players in Global Dental Anesthesia Market
- Pierre Pharma
- Denstply Sirona
- Laboratorios Inibsa
- Primex Pharmaceuticals
- Aspen Group
- Other Key Players
- In April 2022, the STA Single Tooth Anesthesia System was created by Milestone Scientific, a developer of computerized drug delivery injection systems for dental and medical purposes, and Keystone Dental Group, a global medical technology company with capabilities in digital dentistry, implants, prosthetics, and other biomaterial alternatives.
- In December 2021, the US affiliate of the worldwide pharmaceutical business Hikma Pharmaceuticals PLC (Hikma), Hikma Pharmaceuticals USA Inc., announced the release of Bupivacaine HCl Injection, USP. In 10mL and 30mL doses, the business has introduced 0.75%, 0.5%, and 0.25%. Adults are prescribed bupivacaine HCl Injection to provide local or regional anesthetic or analgesia prior to surgery, dentistry or oral surgery, diagnostic or therapeutic treatments, or obstetrical operations.
Report Features Description Market Value (2022) USD 2.3 Bn Forecast Revenue (2032) USD 3.8 Bn CAGR (2023-2032) 5.3% Base Year for Estimation 2022 Historic Period 2016-2022 Forecast Period 2023-2032 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By Product Type- Lidocaine, Mepivacaine, Prilocaine, Articaine, and Other Product Types, By Anesthesia Type- Local, General, Sedation, By Distribution Channel- Pharmacies and Drug Stores, E-Commerce, and Other Distribution Channels, By End-Use- Hospitals, Dental Clinics, and Other End-uses Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; the Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape Pierre Pharma, Denstply Sirona, Laboratorios Inibsa, Primex Pharmaceuticals, Septodont, Aspen Group, 3M, Zeyco, Dentalhitec, and Other Key Players Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)
Frequently Asked Questions (FAQ)What is the value of the global Dental Anesthesia Market?
In 2022, the global Dental Anesthesia Market was valued at USD 2.3 billion.What will be the market size for Dental Anesthesia Market in 2032?
In 2032, the Dental Anesthesia Market will reach USD 3.8 billion.What CAGR is projected for the Dental Anesthesia Market?
The Dental Anesthesia Market is expected to grow at 5.3% CAGR (2023-2032).List the segments encompassed in this report on the Dental Anesthesia Market?
Market.US has segmented the Dental Anesthesia Market Market by geographic (North America, Europe, APAC, South America, and MEA). By Product Type, market has been segmented into Lidocaine, Mepivacaine, Prilocaine, Articaine and Other Product Types. By Anesthesia Type, the market has been further divided into Local, General and Sedation.Which segment dominate the Dental Anesthesia industry?
With respect to the Dental Anesthesia industry, vendors can expect to leverage greater prospective business opportunities through the Lidocaine segment, as this dominate this industry.Name the major industry players in the Dental Anesthesia Market.
Pierre Pharma, Denstply Sirona, Laboratorios Inibsa, Primex Pharmaceuticals, Septodont, Aspen Group and Other Key Players are the main vendors in this market.
- Pierre Pharma
- Denstply Sirona
- Laboratorios Inibsa
- Primex Pharmaceuticals
- Aspen Group
- 3M Company Company Profile
- Other Key Players
| Single User|
USD / per unit
| Multi User|
USD / per unit
| Corporate User|
USD / per unit
|Report Library Access|
|Data Set (Excel)|
|Company Profile Library Access|
|Free Custumization||No||up to 10 hrs work||up to 30 hrs work|
|Accessibility||1 User||2-5 User||Unlimited|
|Analyst Support||up to 20 hrs||up to 40 hrs||up to 50 hrs|
|Benefit||Up to 20% off on next purchase||Up to 25% off on next purchase||Up to 30% off on next purchase|
|Buy Now ($ 3,499)||Buy Now ($ 4,299)||Buy Now ($ 4,999)|